Dandelion Company (the Company) is a public entity with a December 31 fiscal year-end. The Company is an accelerated filer that issues annual and quarterly consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP). We are engaged to perform an integrated audit of the Companys annual U.S. GAAP consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB). The Company has an investment portfolio that is 70 times materiality. The portfolio consists of (1) exchange-traded equity securities and U.S. treasuries that are classified as Level 1 in accordance with the ASC 820 fair value hierarchy and (2) mortgage-backed securities, asset-backed securities, and corporate debt securities that are classified as Level 2. The Company does not have any Level 3 securities. The classification of investment types as of September 30, 20Y2 (see Figure 1 below), is consistent with the classifications as of December 31, 20Y1 (e.g., agency securities as of September 30, 20Y2, remained classified as agency securities as of December 31, 20Y1). We plan to use a control reliance approach to address the risks of material misstatement and assertions related to the Companys investment account balance, including identifying and testing operating effectiveness of the controls that address the risks of material misstatement. The Companys investment professionals are very experienced and have the appropriate skills and capabilities to price and monitor the Companys investment activities. On the basis of interactions during our audit procedures, we believe the vice president of treasury and the risk manager are competent and have the relevant experience.

Fiscal Year 20Y2 Audit Materiality (in millions)

Materiality	Performance Materiality
$150	$105

Prior audit results indicate no history of errors related to the valuation and presentation of investments, and the portfolio composition (e.g., asset class, level) has remained relatively stable in the current year. On the basis of our inquiries of management and our knowledge of the business, we do not expect any significant changes in the Company, market environment, or the portfolio composition between the interim date and year-end. We considered the risk of fraud, as documented in workpaper XXXX, and do not believe a fraud risk is present.

Question	Response
What you learned about Dandelion and its investments.
What are the wrong or problems on Dandelion investment?
Possibility on risk assessment
What's wrong with the fair value of Dandelion investment

Figure 1. Company's investment balances as of September 30, 20Y2 (in millions) Book Value Unreal Gains Unreal Losses Fair Value $ 0 $ 2 98 13 1 Description Debt securities U.S. treasury Agency Residential mortgage-backed Mortgage-backed Asset-backed Corporate debt Total debt securities Equity securities Total debt and equity securities $ 733 5,979 866 306 707 1,543 $10,134 403 $ 735 6,076 874 306 710 1,575 $10,276 349 (1) (5) (1) (1) (3) ($11) (58) 4 35 $153 4 $10,537 $157 (569) $10,625 The classification of investment types as of September 30, 20Y2, is consistent with the classifications as of December 31, 20Y1 (e.g., agency securities as of September 30, 20Y2, remained classified as agency securities at December 31, 20Y1). Figure 1. Company's investment balances as of September 30, 20Y2 (in millions) Book Value Unreal Gains Unreal Losses Fair Value $ 0 $ 2 98 13 1 Description Debt securities U.S. treasury Agency Residential mortgage-backed Mortgage-backed Asset-backed Corporate debt Total debt securities Equity securities Total debt and equity securities $ 733 5,979 866 306 707 1,543 $10,134 403 $ 735 6,076 874 306 710 1,575 $10,276 349 (1) (5) (1) (1) (3) ($11) (58) 4 35 $153 4 $10,537 $157 (569) $10,625 The classification of investment types as of September 30, 20Y2, is consistent with the classifications as of December 31, 20Y1 (e.g., agency securities as of September 30, 20Y2, remained classified as agency securities at December 31, 20Y1)